Cellomics announces $20M fifth round

Sept. 19, 2002 — Cellomics Inc., a Pittsburgh developer of microarrays and other life science tools, announced $20 million in fifth-round financing composed of $15 million in current funding and $5 million of bridge financing from February that had not been previously announced.

Carl Zeiss Jena GmbH led the round. Additional investors include Oxford Bioscience Partners, InterWest Partners, Vector Fund, Alta Partners and Axiom Ventures. All were previous investors in the company.

Cellomics has raised $75 million in venture funding to date. A company spokesman said the company’s goal with current financing is to reach profitability and that it is does not now anticipate further financing.

POST A COMMENT

Easily post a comment below using your Linkedin, Twitter, Google or Facebook account. Comments won't automatically be posted to your social media accounts unless you select to share.